JPMorgan plans contingent interest autocallables linked to Biogen Idec

By Toni Weeks

San Luis Obispo, Calif., Feb. 3 – JPMorgan Chase & Co. plans to price contingent interest autocallable securities due Feb. 24, 2016 linked to Biogen Idec Inc. shares, according to an FWP with the Securities and Exchange Commission.

The notes will pay a contingent quarterly payment of 14.1% per year if the stock closes at or above its 75% interest barrier level on any quarterly review date.

The notes will be called at par plus the contingent payment if the stock closes at or above the initial price on any review date other than the final date.

If the notes have not been called and the final stock price is greater than or equal to the 75% trigger level, the payout at maturity will be par plus the final coupon. If the stock finishes below its 75% barrier level, investors will be fully exposed to the decline in the stock price from its initial level.

The final stock price will be the average of the closing share prices on the five trading days ending Feb. 19, 2016.

The notes (Cusip: 48125UBR2) will price Feb. 6 and settle Feb. 11.

J.P. Morgan Securities LLC is the agent.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.